A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID‑19). Prior to the COVID‑19 pandemic, an established body of knowledge existed about the structure and function of coronaviruses causing diseases like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). This knowledge accelerated the development of various vaccine platforms during early 2020. The initial focus of SARS-CoV-2 vaccines was on preventing symptomatic, often severe illness. On 10 January 2020, the SARS-CoV-2 genetic sequence data was shared through GISAID, and by 19 March, the global pharmaceutical industry announced a major commitment to address COVID-19. The COVID‑19 vaccines are widely credited for their role in reducing the spread, severity, and death caused by COVID-19
COVID 19 Vaccine
Share Article With FriendsFacebook Twitter Linkedin Whatsapp Copy Link URL Copied to clipboard.
We want to restore our region to its former glory.Do you?
During the Golden Age, our region contributed some of the greatest inventions and scientific wonders of the modern world. We are rekindling the spirit of knowledge, glory and hope that inspired the region during this time, and we need you.Join US